At the time of writing, Eton Pharmaceuticals Inc [ETON] stock is trading at $6.91, up 16.33%. An important factor to consider is whether the stock is rising or falling in short-term value. The ETON shares have gain 21.65% over the last week, with a monthly amount glided 49.89%, and seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
Previously, Craig Hallum started tracking the stock with Buy rating on May 06, 2024, and set its price target to $8. H.C. Wainwright reiterated its Buy rating and decreased its price target to $15 on January 04, 2021. B. Riley FBR initiated its recommendation with a Buy and recommended $13.50 as its price target on September 20, 2019. H.C. Wainwright started tracking with a Buy rating for this stock on June 10, 2019, and assigned it a price target of $15.
For the past year, the stock price of Eton Pharmaceuticals Inc fluctuated between $3.03 and $6.25. Currently, Wall Street analysts expect the stock to reach $8.5 within the next 12 months. Eton Pharmaceuticals Inc [NASDAQ: ETON] shares were valued at $6.91 at the most recent close of the market. An investor can expect a potential return of 23.01% based on the average ETON price forecast.
Analyzing the ETON fundamentals
According to Eton Pharmaceuticals Inc [NASDAQ:ETON], the company’s sales were 31.38M for trailing twelve months, which represents an -24.36% plunge. Gross Profit Margin for this corporation currently stands at 0.59% with Operating Profit Margin at -0.2%, Pretax Profit Margin comes in at -0.2%, and Net Profit Margin reading is -0.21%. To continue investigating profitability, this company’s Return on Assets is posted at -0.21, Equity is -0.44 and Total Capital is -0.46. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.36.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 6.30 points at the first support level, and at 5.69 for the second support level. However, for the 1st resistance point, the stock is sitting at 7.22, and for the 2nd resistance point, it is at 7.53.
Ratios To Look Out For
It is important to note that Eton Pharmaceuticals Inc [NASDAQ:ETON] has a current ratio of 1.40. On the other hand, the Quick Ratio is 1.28, and the Cash Ratio is 0.97. Considering the valuation of this stock, the price to sales ratio is 5.69, the price to book ratio is 13.22.
Transactions by insiders
Recent insider trading involved Opaleye Management Inc., 10% Owner, that happened on Sep 10 ’24 when 57500.0 shares were purchased. 10% Owner, Opaleye Management Inc. completed a deal on Sep 11 ’24 to buy 50000.0 shares.
